The invention relates to a Chinese medicinal composition, in particular to a Chinese medicament for treating myocardial infarction, which is prepared from the following raw materials in part by weight: 3 to 5 parts of siberian cocklour fruit, 4 to 6 parts of biond magnolia flower, 4 to 6 parts of folium eucalypti, 2 to 4 parts of golden-rod solidago, 3 to 5 parts of common dayflower herb, 2 to 4 parts of feather cockscomb seed, 1 to 3 parts of gentiana scabra bge, 2 to 4 parts of densefruit pittany root-bark, 1 to 3 parts of ash bark, 2 to 4 parts of rhizome paridis, 2 to 4 parts of juncus pith, 1 to 3 parts of java brucea fruit, 3 to 5 parts of Chinese pasque-flower, 4 to 6 parts of lotus rhizome node, 1 to 3 parts of cattail pollen, 1 to 3 parts of India madder root, 2 to 4 parts of rosewood heart wood, 3 to 5 parts of carbonized human hair, 2 to 4 parts of garden burnet root, 2 to 4 parts of common bletilla pseudobulb, 3 to 5 parts of szechuan lovage rhizome, 1 to 3 parts of yanhusuo, 1 to 3 parts of radix curcumae and 3 to 5 parts of curcuma longa. The Chinese medicinal composition has the advantages of good curative effect, quick response, small administration dosage, convenient use and no toxic or side effect, and has the effects of calming and stopping pain, improving microcirculation, reducing the resistance of peripheral blood vessels, relieving cardiac stress and improving myocardial ischemia.